✨ Education and Health Notices




Education

Private Schools Conditional Integration Act 1975

Supplementary Integration Agreements

Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that supplementary integration agreements have been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Schools and Student Support, Ministry of Education, pursuant to delegated authority, and the proprietors of the following schools:

  • Hato Petera College, Northcote (33)
  • St Francis Catholic School, Point Chevalier (1488)
  • Christ The King Catholic School, Owairaka (1245)
  • St Anne’s Catholic School, Manurewa (1486)
  • Cornerstone Christian School, Palmerston North (1172)

The said supplementary integration agreements were executed on 7 October 2014.

Copies of the supplementary integration agreements are available for inspection without charge by any member of the public via the following email addresses:

  • enquiries.auckland@minedu.govt.nz
  • enquiries.whanganui@minedu.govt.nz

Dated at Wellington this 7th day of October 2014.

JIM GREENING, Group Manager, Schools and Student Support.

go6398

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Nimenrix

Active Ingredients:

  • Neisseria meningitidis Group A polysaccharide 5mcg
  • Neisseria meningitidis Group C polysaccharide 5mcg
  • Neisseria meningitidis Group W135 polysaccharide 5mcg
  • Neisseria meningitidis Group Y polysaccharide 5mcg
  • Tetanus toxoid 44mcg

Dosage Form: Powder for injection with diluent
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturers:

  • GlaxoSmithKline Biologicals SA, Rixensart, Belgium
  • GlaxoSmithKline Biologicals SA, Wavre, Belgium

Product: Ultibro Breezhaler 110/50

Active Ingredients:

  • Glycopyrronium bromide 63 mcg equivalent to Glycopyrronium 50mcg
  • Indacaterol maleate 143 mcg equivalent to Indacaterol 110mcg

Dosage Form: Powder filled inhalation capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers:

  • Novartis Pharma Stein AG, Stein, Switzerland
  • Novartis Pharma Schweizerhalle AG, Schweizerhalle, Switzerland

Dated this 10th day of October 2014.

STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go6365

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Varilrix Vaccine

Active Ingredient: Varicella vaccine 2000PFU

Dosage Form: Powder for injection with diluent
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 127





✨ LLM interpretation of page content

πŸŽ“ Supplementary Integration Agreements for Private Schools

πŸŽ“ Education, Culture & Science
7 October 2014
Private Schools, Integration Agreements, Catholic Schools, Christian Schools, Auckland, Palmerston North
  • JIM GREENING, Group Manager, Schools and Student Support

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
10 October 2014
Medicines, Distribution, Nimenrix, Ultibro Breezhaler, Vaccines, Pharmaceuticals
  • STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of a New Medicine (Varilrix Vaccine)

πŸ₯ Health & Social Welfare
10 October 2014
Medicines, Distribution, Varilrix Vaccine, Vaccines, Pharmaceuticals
  • STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health